{
  "JPMorgan Chase & Co.": {
    "2023": {
      "FORM": "8-K",
      "CATEGORIES": {
        "Section 5 - Corporate Governance and Management": {
          "ITEMS": {
            "Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers": {
              "content": "JPMorgan Chase & Co. (the “Firm”) elected Alicia Boler Davis as a director, effective March 20, 2023. Ms. Davis is the Chief Executive Officer of Alto Pharmacy. Ms. Davis' appointment to a board committee will be disclosed when determined. She was also elected a director of JPMorgan Chase Bank, N.A. and a manager of JPMorgan Chase Holdings LLC, and may be elected a director of such other subsidiary or subsidiaries as may be determined from time to time. A copy of the press release announcing this election is attached hereto as Exhibit 99.1.",
              "subsections": {}
            }
          }
        },
        "Section 9 - Financial Statements and Exhibits": {
          "ITEMS": {
            "Item 9.01 - Financial Statements and Exhibits": {
              "content": "(d) Exhibit",
              "subsections": {
                "exhibit_list": "Exhibit No. 99.1: JPMorgan Chase & Co Press Release dated January 17, 2023.\nExhibit No. 101: Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).\nExhibit No. 104: Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)."
              }
            }
          }
        }
      }
    }
  }
}